Using K-M curves and log-rank tests, the high SOAT1 expression was found to be associated with poor prognosis in overall and grade 3 gliomas, but not in grade 2 gliomas and GBM (Figures 2A–D). Here, SOAT1 is linked to central nervous system cancer.